EarningsQ2 2024 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q2 2024 Earnings Report

0 Followers

MX:ARWR Q2 2024 EPS Results

Actual EPS-$18.36

Consensus EPS-$8.50

Beat/MissMissed by -$9.87

One Year Ago EPS$8.10

Actual Revenue$0.00

Expected Revenue$755.68M

Beat/MissMissed by -$755.68M

YoY Revenue Growth-100.00%

QuarterQ2 2024

Date05/09/2024

TimeAfter Close

Conference CallThursday, May 9, 2024

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-27.93 / -	-1.981	―
Aug 04, 2026	2026 (Q3)	-22.99 / -24.49	-22.686	-7.94% (-1.80)
May 07, 2026	2026 (Q2)	-19.72 / -16.74	49.513	-133.82% (-66.26)
Feb 05, 2026	2026 (Q1)	0.67 / 3.96	-25.027	115.83% (+28.99)
Nov 25, 2025	2025 (Q4)	-2.02 / -1.98	-24.486	91.91% (+22.51)
Aug 07, 2025	2025 (Q3)	-17.14 / -22.69	-24.847	8.70% (+2.16)
May 12, 2025	2025 (Q2)	-3.37 / 49.51	-18.365	369.61% (+67.88)
Feb 10, 2025	2025 (Q1)	-8.57 / -25.03	-22.326	-12.10% (-2.70)
Nov 26, 2024	2024 (Q4)	-20.17 / -24.49	-18.365	-33.33% (-6.12)
Aug 08, 2024	2024 (Q3)	-9.52 / -24.85	-17.285	-43.75% (-7.56)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed